Skip to main content
. Author manuscript; available in PMC: 2022 Sep 3.
Published before final editing as: Psychol Med. 2021 Mar 3:1–11. doi: 10.1017/S0033291721000398

Table 1.

Descriptive statistics and correlation matrix of main study variables

1 2 3 4 5 6 7 8 9 10 11 12 13
1. Age
2. Female −.11**
3. T1 MDD SX −.12** .11**
4. T1 GAD SX −.07 .08 .29***
5. T1 PD SX −.09* .15*** .32*** .23***
6. T2 VF −.20*** −.011 −.04 −.06 −.07
7. T2 NS −.13** −.16*** −.12** −.10* −.12** .35***
8. T2 BC −.27*** −.14*** −.08* −.08* −.11* .34*** .44***
9. T2 SGST .05 −.03 −.08 −.09* −.05 .13** .24*** .22***
10. T2 BDS −.09* −.10 −.11** −.09* −.12** .22*** .41*** .36*** .23***
11. T3 IL-6 .40*** −.02 .05 .09* .01 −.24*** −.22*** −.23*** −.04 −.09*
12. T3 CRP .04 .15*** .14*** .09* .01 −.14*** −.17*** −.13** −.08 −.08* .54***
13. T3 FGN .25*** .12** .08* .031 .05 −.08* −.13** −.17*** −.08 −.05 .45*** .51***
M or n 51.78 309 0.78 0.16 0.47 21.41 2.80 41.60 0.98 5.21 0.71 0.28 5.81
s.d. or % 13.44 50.33 1.88 0.97 1.24 6.21 1.47 10.84 0.03 1.52 0.53 0.79 0.13
Min 25.00 0.00 0.00 0.00 4.00 0.00 8.00 0.93 0.00 0.00 −0.71 5.65
Max 76.00 7.00 10.00 6.00 44.00 5.00 90.00 1.00 8.00 1.38 1.36 5.99
Skewness −0.16 −0.01 2.18 6.84 2.81 0.20 −0.15 0.28 −0.76 0.12 −0.05 0.10 0.08
Kurtosis −1.02 −2.01 3.13 50.86 7.21 0.02 −1.00 0.35 −1.04 −0.39 −1.51 −1.50 −1.43

M, mean; n, number of participants; s.d., standard deviation; Min, minimum; Max, maximum; BC, backward counting; CRP, C-reactive protein; DBS, digit backward span; FGN, fibrinogen; GAD, generalized anxiety disorder; IL-6, interleukin-6; MDD, major depressive disorder; NS, number series; PD, panic disorder; SGST, stop-and-go-switch task mixed task; SX, symptom severity; T1, time 1; T2, time 2; T3, time 3; VF, verbal fluency.

Inflammation serum levels have been log transformed to achieve univariate normal distributions of the data. IL-6 was originally measured in pg/ml, fibrinogen in mg/dl, and CRP in μg/ml.

***

p ⩽ 0.001;

**

p ⩽ 0.01;

*

p ⩽ 0.05.